Defects in PPARγ were reported to result in different pathological conditions in metabolic syndrome, including insulin resistance, obesity, dyslipidemia, and hypertension, and largely increase the risk of type 2 diabetes, cardiovascular diseases, and cancer [95,96]. This evidence concerns the gene PPARG and metabolic syndrome.